A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
Researchers in Sweden say a tool, known as Stockholm3, finds 90 per cent of 'clinically significant' prostate cancers, compared with 74 per cent uncovered by the standard prostate-specific antigen ...
A new blood-based screening test could significantly improve the detection of aggressive prostate cancer compared with the widely used prostate-specific antigen (PSA) test, according to a new ...